Clinical Trial Update: FeAsiBility of a Treatment Free Interval in Newly Diagnosed MM Patients Treated With Daratumumab-lenalidomide-dexamethasone (HOVON174MM) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial (HOVON174MM) evaluating a treatment-free interval in newly diagnosed multiple myeloma patients treated with daratumumab-lenalidomide-dexa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Daratumumab (daratumumab)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland | Conditions: Multiple Myeloma | Phase 3 | Status: RECRUITING